RxDoctor Payments Data

Reynaldo Gomez Adrover, MD

General Practice · Manati, PRNPI 1124025358

Payments from drug & device makers

$1,841in general payments, 2019–2025

Across 90 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$409
  • Novo Nordisk$353
  • AstraZeneca$243
  • Teva Pharmaceuticals USA, Inc.$225
  • Johnson & Johnson$135
  • GSK$104
  • plus $372 from 9 others

What the payments were for

  • Food & beverage$1,841100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,841 in reported general payments places this provider in the 90th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$6,596
Medicare patients
16
Services billed
125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SynjardyEmpagliflozin/Metformin Hcl223$189,268
OzempicSemaglutide136$133,203
JardianceEmpagliflozin71$80,857
FarxigaDapagliflozin Propanediol102$74,950
EliquisApixaban79$54,628
TrulicityDulaglutide50$51,321
SynthroidLevothyroxine Sodium377$42,578
XareltoRivaroxaban41$38,083
Jentadueto XrLinagliptin/Metformin Hcl45$30,123
Janumet XrSitagliptin Phos/Metformin Hcl33$29,225
Xigduo XrDapaglifloz Propaned/Metformin29$27,392
JanumetSitagliptin Phos/Metformin Hcl36$26,390
Synjardy XrEmpagliflozin/Metformin Hcl31$26,106
TradjentaLinagliptin22$22,304
Breo ElliptaFluticasone/Vilanterol52$20,400

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimSynjardy, Jardiance, Jentadueto Xr, Synjardy Xr, Tradjenta$409$395,161452 claims
Novo NordiskOzempic$353$133,203136 claims
MerckJanumet Xr, Janumet, Januvia$20$75,64196 claims
AstraZenecaFarxiga$243$74,950102 claims
AbbVieSynthroid, Linzess$24$53,007396 claims
GSKBreo Ellipta, Trelegy Ellipta$104$39,69781 claims
Johnson & JohnsonXarelto$135$38,08341 claims
Sanofi-aventis U.S. LLCLantus$81$18,118134 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in Manati

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →